tiprankstipranks

Perceptive Advisors Llc Insider Profile

116 Followers
Perceptive Advisors Llc, Ten Percent Owner at Amicus, holds 5.36M shares in Acrivon Therapeutics, Inc. (Ticker: ACRV), holds 9.28M shares in Aldeyra Therapeutics (Ticker: ALDX), holds 10.79M shares in Cerevel Therapeutics Holdings (Ticker: CERE). Most recently, Perceptive Advisors Llc Bought ― shares of Acrivon Therapeutics, Inc. on Apr 15, 2024 for an estimated value of 20.00M.
tipranks
Perceptive Advisors Llc

Perceptive Advisors Llc
Amicus (FOLD)
Ten Percent Owner

Ranked #297 out of 98,564 Corporate Insiders

Profitable Transactions

45%
86 out of 190 Profitable Transactions

Average Return

+18.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2B
21.46%
18.83%
11.14%
10.51%
38.06% Others
A breakdown of Perceptive Advisors Llc's holdings

Insider Roles

Cerevel Therapeutics Holdings
(CERE)
Director
Landos Biopharma
(LABP)
Ten Percent Owner
Crinetics Pharmaceuticals
(CRNX)
Ten Percent Owner
Amicus
(FOLD)
Ten Percent Owner
+20 other positions
Roles that Perceptive Advisors Llc holds in companies

Most Profitable Insider Trade

Stock:
Soleno Therapeutics
(SLNO)
Rating:Informative Buy
Date:May 26, 2023 - Today
Return:+614.20%
The most profitable trade made by Perceptive Advisors Llc

Perceptive Advisors Llc's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amicus
Oct 05, 2018
Ten Percent Owner
Informative Buy
629.70K
$221.96M
ARAV
Aravive
Sep 25, 2017
Informative Sell
7.00M
$151.90K
CORI
Corium
Oct 15, 2018
Informative Sell
45.46M
$34.55M
ZGNX
Zogenix
Aug 14, 2018
Informative Buy
5.20M
$108.60M
QTNTQ
Quotient
Nov 02, 2022
Informative Sell
660.45K
$309.86K
GBT
Global Blood Therapeutics
Dec 19, 2017
Informative Buy
6.65M
$334.85M
ALBO
Albireo Pharma
Oct 13, 2022
Informative Sell
9.51M
$85.64M
Solid Biosciences
Jan 12, 2024
Director, Ten Percent Owner
Informative Buy
18.86M
$62.92M
LJPC
La Jolla Pharma
Jan 09, 2019
Informative Sell
11.72M
$14.02M
Motus Gi Holdings
Jan 22, 2021
Ten Percent Owner
Informative Sell
2.53M
$186.24K
DOVA
Dova Pharmaceuticals
Nov 15, 2019
Uninformative Sell
$0.00
Meiragtx Holdings
May 15, 2023
Director, Ten Percent Owner
Informative Buy
25.00M
$55.62M
Agile Therapeutics
Oct 15, 2021
Ten Percent Owner
Informative Buy
4.87M
$8.01M
Verrica Pharmaceuticals
Dec 29, 2023
Ten Percent Owner
Informative Buy
2.31M
$48.63M
ATNXQ
Athenex
Sep 14, 2020
Informative Buy
22.05M
$202.99K
ADMA Biologics
Sep 30, 2021
Ten Percent Owner
Informative Sell
299.24K
$86.74M
KDMN
Kadmon Holdings
Nov 18, 2019
Informative Buy
5.00M
$139.05M
Crinetics Pharmaceuticals
Apr 18, 2022
Ten Percent Owner
Informative Buy
3.50M
$235.30M
Lyra Therapeutics
Jun 02, 2023
Director, Ten Percent Owner
Informative Buy
8.99M
$66.47M
VYNE Therapeutics
Aug 18, 2021
Ten Percent Owner
Informative Sell
435.00K
$11.45M
Leap Therapeutics
Jun 24, 2020
Ten Percent Owner
Informative Buy
3.50M
$27.12M
Athira Pharma
Dec 29, 2023
Director, Ten Percent Owner
Informative Buy
1.46M
$11.02M
Cerevel Therapeutics Holdings
Feb 21, 2024
Director
Uninformative Sell
$453.28M
Astria Therapeutics
Feb 05, 2024
Director
Informative Buy
30.00M
$62.52M
Landos Biopharma
Feb 09, 2021
Ten Percent Owner
Informative Buy
3.21M
$397.83M
RXDX
Prometheus Biosciences
Mar 16, 2021
Uninformative Buy
$662.54M
RAIN
Rain Oncology
Oct 13, 2021
Informative Sell
667.48K
$3.01M
Nautilus Biotechnolgy
Dec 10, 2021
Director
Informative Buy
1.07M
$22.69M
ISO
IsoPlexis
Oct 14, 2021
Uninformative Buy
$3.12M
LianBio Sponsored ADR
Feb 20, 2024
Director, Ten Percent Owner
Uninformative Sell
182.96K
$16.29M
Soleno Therapeutics
Sep 28, 2023
Ten Percent Owner
Informative Buy
15.11M
$123.41M
CARGO Therapeutics, Inc.
Nov 14, 2023
Former 10% Owner
Uninformative Buy
$6.33M
Acrivon Therapeutics, Inc.
Apr 15, 2024
Ten Percent Owner
Informative Buy
20.00M
$52.64M
Talphera
Jun 21, 2017
Ten Percent Owner
Informative Sell
2.10M
$5.67M
Aldeyra Therapeutics
Apr 08, 2024
Ten Percent Owner
Informative Buy
833.87K
$36.27M
VBI Vaccines
Apr 06, 2023
Ten Percent Owner
Informative Sell
1.48M
$25.20M
Heron Therapeutics
Jul 07, 2011
Ten Percent Owner
Informative Buy
$74.67M
AEGR
Aegerion
Sep 09, 2013
Informative Buy
5.00M
$5.56M
~RPRX
Repros
Mar 19, 2013
Informative Sell
25.25M
$544.42K
GEVA
Synageva
Nov 08, 2011
Uninformative Sell
List of latest transactions for each holding click on a transaction to see Perceptive Advisors Llc's performance on stock

Perceptive Advisors Llc insider profile FAQ

What is the percentage of profitable transactions made by Perceptive Advisors Llc?
The percentage of profitable transactions made by Perceptive Advisors Llc is 45%.
    What is the average return per transaction made by Perceptive Advisors Llc?
    The average return per transaction made by Perceptive Advisors Llc is 18.00%.
      What stocks does Perceptive Advisors Llc hold?
      Perceptive Advisors Llc holds: FOLD, ARAV, CORI, ZGNX, QTNTQ, GBT, ALBO, SLDB, LJPC, MOTS, DOVA, MGTX, AGRX, VRCA, ATNXQ, ADMA, KDMN, CRNX, LYRA, VYNE, LPTX, ATHA, CERE, ATXS, LABP, RXDX, RAIN, NAUT, ISO, LIANY, SLNO, CRGX, ACRV, TLPH, ALDX, VBIV, HRTX, AEGR, ~RPRX, GEVA stocks.
        What was Perceptive Advisors Llc’s latest transaction?
        Perceptive Advisors Llc latest transaction was an Informative Buy of $20.00M.
          What was Perceptive Advisors Llc's most profitable transaction?
          Perceptive Advisors Llc’s most profitable transaction was an Informative Buy of SLNO stock on May 26, 2023. The return on the trade was 614.20%.
            What is Perceptive Advisors Llc's role in Amicus?
            Perceptive Advisors Llc's role in Amicus is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.